Results 111 to 120 of about 461,561 (166)
Long-term outcomes of eribulin‑based neoadjuvant chemotherapy for triple‑negative breast cancer patients stratified by homologous recombination deficiency status: results of the randomized JBCRG-22 study. [PDF]
Breast Cancer Res TreatMasuda N +17 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Pharmaceutical Sciences—1968. A Literature Review of Pharmaceutics
Journal of Pharmaceutical Sciences, 1969This review of the literature represents a comprehensive cross section of the research and development efforts in various selected disciplines of the pharmaceutical sciences. It is the ninth annual survey in the series (1–8). To compile it, numerous periodicals and selected sections of Chemical Abstracts were abstracted.
P D, Bernardo, E J, Russo
openaire +2 more sources
Revolutionizing Pharmaceutical Sciences
Artificial Intelligence (AI) is revolutionizing the pharmaceutical sciences by significantly impacting drug discovery and development, which traditionally is a lengthy, difficult, and costly process often resulting in unrewarded investments. AI has given a way in accelerating the drug discovery cycle, reducing costs, and integrating the 3R principles ...Ch. Hima Bindu +5 more
openaire +1 more source
Pharmaceutical Sciences—1970: Literature Review of Pharmaceutics
Journal of Pharmaceutical Sciences, 1971T L, Benney, W E, Hamlin
openaire +2 more sources
Pharmaceutical Sciences — 1973: Literature Review of Pharmaceutics
Journal of Pharmaceutical Sciences, 1974A K, Herd, J K, Haleblian
openaire +2 more sources
Pharmaceutical Sciences—1974: Literature Review of Pharmaceutics
Journal of Pharmaceutical Sciences, 1975J K, Haleblian, F W, Goodhart
openaire +2 more sources